These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32505212)

  • 1. Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
    Sundaram G; Lim CK; Brew BJ; Guillemin GJ
    J Neuroinflammation; 2020 Jun; 17(1):176. PubMed ID: 32505212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
    Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
    Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway.
    Jand Y; Ghahremani MH; Ghanbari A; Ejtemaei-Mehr S; Guillemin GJ; Ghazi-Khansari M
    Sci Rep; 2022 Sep; 12(1):15963. PubMed ID: 36153399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
    Lemos H; Mohamed E; Ou R; McCardle C; Zheng X; McGuire K; Homer NZM; Mole DJ; Huang L; Mellor AL
    Front Immunol; 2020; 11():1256. PubMed ID: 32625215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
    Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
    Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
    Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDO expression in the brain: a double-edged sword.
    Kwidzinski E; Bechmann I
    J Mol Med (Berl); 2007 Dec; 85(12):1351-9. PubMed ID: 17594069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.
    Sakurai K; Zou JP; Tschetter JR; Ward JM; Shearer GM
    J Neuroimmunol; 2002 Aug; 129(1-2):186-96. PubMed ID: 12161035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
    Chatterjee P; Zetterberg H; Goozee K; Lim CK; Jacobs KR; Ashton NJ; Hye A; Pedrini S; Sohrabi HR; Shah T; Asih PR; Dave P; Shen K; Taddei K; Lovejoy DB; Guillemin GJ; Blennow K; Martins RN
    J Neuroinflammation; 2019 Oct; 16(1):186. PubMed ID: 31601232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons.
    O'Farrell K; Fagan E; Connor TJ; Harkin A
    Eur J Pharmacol; 2017 Sep; 810():163-173. PubMed ID: 28688912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
    Breda C; Sathyasaikumar KV; Sograte Idrissi S; Notarangelo FM; Estranero JG; Moore GG; Green EW; Kyriacou CP; Schwarcz R; Giorgini F
    Proc Natl Acad Sci U S A; 2016 May; 113(19):5435-40. PubMed ID: 27114543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
    J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central Nervous System Infection with Borna Disease Virus Causes Kynurenine Pathway Dysregulation and Neurotoxic Quinolinic Acid Production.
    Formisano S; Hornig M; Yaddanapudi K; Vasishtha M; Parsons LH; Briese T; Lipkin WI; Williams BL
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain.
    Ciapała K; Pawlik K; Ciechanowska A; Mika J; Rojewska E
    Toxicol Appl Pharmacol; 2023 Feb; 461():116382. PubMed ID: 36681127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
    Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
    J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease.
    Sundaram G; Bessede A; Gilot D; Staats Pires A; Sherman LS; Brew BJ; Guillemin GJ
    Int J Tryptophan Res; 2022; 15():11786469221118657. PubMed ID: 36004319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
    Song P; Ramprasath T; Wang H; Zou MH
    Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of system x
    Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
    J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG
    Wetzel LA; Hurtado M; MacDowell Kaswan ZA; McCusker RH; Steelman AJ
    Brain Behav Immun Health; 2020 Aug; 7():100116. PubMed ID: 34589873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.